Pro-Pharmaceuticals, Inc. (Amex: PRW), today announced that the U.S. FDA has granted an Investigational New Drug application for use of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE